Payment overview · 2025
General Payments
$33.90
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Dean Culler, PA
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant · MOUNT AIRY, NC · NPI 1053424598
Verified facts
What the public records show
CMS Open Payments records show Michael Dean Culler, PA received $33.90 in general payments during 2025 across 1 reported records.
E.R. Squibb & Sons, L.L.C. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 444 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $33.90 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $33.90 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| COBENFY Normalized: cobenfy |
Drug | E.R. Squibb & Sons, L.L.C. | $33.90 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
444 | 57 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Furosemide | Furosemide | 966 | 123 |
| Levothyroxine Sodium | Levothyroxine Sodium | 872 | 103 |
| Amlodipine Besylate | Amlodipine Besylate | 643 | 81 |
| Atorvastatin Calcium | Atorvastatin Calcium | 611 | 76 |
| Gabapentin | Gabapentin | 506 | 73 |
| Lisinopril | Lisinopril | 453 | 54 |
| Eliquis | Apixaban | 444 | 57 |
| Omeprazole | Omeprazole | 436 | 69 |
| Mirtazapine | Mirtazapine | 435 | 65 |
| Pantoprazole Sodium | Pantoprazole Sodium | 435 | 60 |
| Sertraline Hcl | Sertraline Hcl | 420 | 60 |
| Trazodone Hcl | Trazodone Hcl | 386 | 59 |
| Escitalopram Oxalate | Escitalopram Oxalate | 372 | 43 |
| Memantine Hcl | Memantine Hcl | 369 | 44 |
| Donepezil Hcl | Donepezil Hcl | 350 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 339 | 43 |
| Divalproex Sodium | Divalproex Sodium | 337 | 51 |
| Potassium Chloride | Potassium Chloride | 307 | 45 |
| Quetiapine Fumarate | Quetiapine Fumarate | 307 | 43 |
| Famotidine | Famotidine | 293 | 35 |
| Metoprolol Succinate | Metoprolol Succinate | 276 | 38 |
| Losartan Potassium | Losartan Potassium | 270 | 36 |
| Montelukast Sodium | Montelukast Sodium | 252 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 251 | 34 |
| Meloxicam | Meloxicam | 237 | 33 |
| Lorazepam | Lorazepam | 233 | 53 |
| Tamsulosin Hcl | Tamsulosin Hcl | 221 | 29 |
| Metformin Hcl | Metformin Hcl | 200 | 21 |
| Buspirone Hcl | Buspirone Hcl | 198 | 24 |
| Tramadol Hcl | Tramadol Hcl | 193 | 44 |
| Carvedilol | Carvedilol | 184 | 21 |
| Simvastatin | Simvastatin | 184 | 19 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 177 | 32 |
| Alprazolam | Alprazolam | 161 | 32 |
| Pravastatin Sodium | Pravastatin Sodium | 155 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 152 | 20 |
| Clonazepam | Clonazepam | 143 | 23 |
| Levetiracetam | Levetiracetam | 141 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 138 | 29 |
| Olanzapine | Olanzapine | 137 | 16 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 136 | 33 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 127 | 21 |
| Topiramate | Topiramate | 125 | 12 |
| Allopurinol | Allopurinol | 121 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 114 | 16 |
| Benztropine Mesylate | Benztropine Mesylate | 102 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 93 | 19 |
| Myrbetriq | Mirabegron | 93 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 91 | suppressed |
| Finasteride | Finasteride | 85 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 85 | 14 |
| Risperidone | Risperidone | 84 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 82 | 25 |
| Valsartan | Valsartan | 82 | suppressed |
| Xarelto | Rivaroxaban | 80 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 79 | 57 |
| Divalproex Sodium Er | Divalproex Sodium | 78 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 78 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 78 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 74 | 12 |
| Metformin Hcl Er | Metformin Hcl | 74 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 71 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 70 | 20 |
| Nystatin | Nystatin | 70 | 36 |
| Oxybutynin Chloride | Oxybutynin Chloride | 69 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 67 | 41 |
| Dicyclomine Hcl | Dicyclomine Hcl | 65 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 65 | 49 |
| Lamotrigine | Lamotrigine | 65 | suppressed |
| Glipizide | Glipizide | 64 | suppressed |
| Prednisone | Prednisone | 63 | 31 |
| Januvia | Sitagliptin Phosphate | 59 | suppressed |
| Novolog Flexpen | Insulin Aspart | 58 | suppressed |
| Pregabalin | Pregabalin | 58 | 13 |
| Lactulose | Lactulose | 55 | 20 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 55 | suppressed |
| Nyamyc | Nystatin | 54 | 30 |
| Aripiprazole | Aripiprazole | 53 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 52 | 21 |
| Bupropion Xl | Bupropion Hcl | 52 | suppressed |
| Mupirocin | Mupirocin | 52 | 34 |
| Rivastigmine | Rivastigmine Tartrate | 51 | suppressed |
| Latanoprost | Latanoprost | 50 | 13 |
| Azithromycin | Azithromycin | 49 | 42 |
| Propranolol Hcl | Propranolol Hcl | 49 | suppressed |
| Sucralfate | Sucralfate | 49 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 48 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 47 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 46 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | suppressed |
| Digoxin | Digoxin | 45 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 43 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 42 | 22 |
| Bupropion Hcl | Bupropion Hcl | 41 | suppressed |
| Spironolactone | Spironolactone | 41 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 40 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 39 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 39 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 38 | suppressed |
| Linzess | Linaclotide | 37 | suppressed |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 37 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 37 | suppressed |
| Carbamazepine | Carbamazepine | 36 | suppressed |
| Cephalexin | Cephalexin | 36 | 12 |
| Diltiazem 24hr Er | Diltiazem Hcl | 36 | suppressed |
| Torsemide | Torsemide | 36 | suppressed |
| Levofloxacin | Levofloxacin | 35 | 27 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 35 | 20 |
| Ezetimibe | Ezetimibe | 34 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 33 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 33 | suppressed |
| Ibuprofen | Ibuprofen | 33 | 12 |
| Valacyclovir | Valacyclovir Hcl | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Fluconazole | Fluconazole | 32 | 20 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 20 |
| Atenolol | Atenolol | 30 | suppressed |
| Pentoxifylline | Pentoxifylline | 30 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Baclofen | Baclofen | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 27 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Clozapine | Clozapine | 26 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 26 | suppressed |
| Glimepiride | Glimepiride | 25 | suppressed |
| Olanzapine Odt | Olanzapine | 25 | suppressed |
| Paliperidone Er | Paliperidone | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Celecoxib | Celecoxib | 24 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 24 | suppressed |
| Haloperidol | Haloperidol | 24 | suppressed |
| Jardiance | Empagliflozin | 24 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 23 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 21 | 14 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 20 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 19 | suppressed |
| Levemir | Insulin Detemir | 19 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 19 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 19 | suppressed |
| Nystop | Nystatin | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | 11 |
| Bumetanide | Bumetanide | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Hydrocortisone | Hydrocortisone | 17 | 11 |
| Insulin Lispro | Insulin Lispro | 17 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Temazepam | Temazepam | 17 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 16 | suppressed |
| Fetzima | Levomilnacipran Hcl | 16 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 16 | suppressed |
| Lumigan | Bimatoprost | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 15 | suppressed |
| Galantamine Er | Galantamine Hbr | 15 | suppressed |
| Nadolol | Nadolol | 15 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 14 | suppressed |
| Gemtesa | Vibegron | 14 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 14 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 14 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 14 | suppressed |
| Travoprost | Travoprost | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 13 | suppressed |
| Niacin Er | Niacin | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Humira(Cf) Pen | Adalimumab | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | 11 |
| Nitroglycerin | Nitroglycerin | 12 | 11 |
| Perphenazine | Perphenazine | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Amantadine | Amantadine Hcl | 11 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | 11 |
| Estradiol | Estradiol | 11 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 11 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 11 | suppressed |
| Rhopressa | Netarsudil Mesylate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $33.90 · 1 records | E.R. Squibb & Sons, L.L.C. | COBENFY | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error